The	O
Netherlands	B:C0242481
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
(	O
Netherlands	O
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
)	O
protocol	O
to	O
assess	O
the	O
risk	O
of	O
late	O
complications	O
following	O
Chlamydia	O
trachomatis	I:C0518948
infection	I:C0518948
in	O
women	O
.	O

The	O
Netherlands	O
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
(	O
Netherlands	B:C0242481
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
)	O
protocol	O
to	O
assess	O
the	O
risk	O
of	O
late	O
complications	O
following	O
Chlamydia	O
trachomatis	I:C0518948
infection	I:C0518948
in	O
women	O
.	O

The	O
Netherlands	O
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
(	O
Netherlands	O
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
)	O
protocol	B:C2348563
to	O
assess	O
the	O
risk	O
of	O
late	O
complications	O
following	O
Chlamydia	O
trachomatis	I:C0518948
infection	I:C0518948
in	O
women	O
.	O

The	O
Netherlands	O
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
(	O
Netherlands	O
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
)	O
protocol	O
to	O
assess	O
the	O
risk	O
of	O
late	O
complications	B:C0009566
following	O
Chlamydia	O
trachomatis	I:C0518948
infection	I:C0518948
in	O
women	O
.	O

The	O
Netherlands	O
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
(	O
Netherlands	O
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
)	O
protocol	O
to	O
assess	O
the	O
risk	O
of	O
late	O
complications	O
following	O
Chlamydia	B:C0518948
trachomatis	I:C0518948
infection	I:C0518948
in	O
women	O
.	O

The	O
Netherlands	O
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
(	O
Netherlands	O
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
)	O
protocol	O
to	O
assess	O
the	O
risk	O
of	O
late	O
complications	O
following	O
Chlamydia	O
trachomatis	I:C0518948
infection	I:C0518948
in	O
women	B:C0043210
.	O

Chlamydia	B:C0008151
trachomatis	I:C0008151
(	O
Chlamydia	O
trachomatis	I:C0008151
)	O
,	O
the	O
most	O
common	O
bacterial	O
sexually	I:C0036917
transmitted	I:C0036917
infection	I:C0036917
(	O
sexually	O
transmitted	I:C0036917
infection	I:C0036917
)	O
among	O
young	O
women	O
,	O
can	O
result	O
in	O
serious	O
sequelae	O
.	O

Chlamydia	O
trachomatis	I:C0008151
(	O
Chlamydia	B:C0008151
trachomatis	I:C0008151
)	O
,	O
the	O
most	O
common	O
bacterial	O
sexually	I:C0036917
transmitted	I:C0036917
infection	I:C0036917
(	O
sexually	O
transmitted	I:C0036917
infection	I:C0036917
)	O
among	O
young	O
women	O
,	O
can	O
result	O
in	O
serious	O
sequelae	O
.	O

Chlamydia	O
trachomatis	I:C0008151
(	O
Chlamydia	O
trachomatis	I:C0008151
)	O
,	O
the	O
most	O
common	O
bacterial	B:C0036917
sexually	I:C0036917
transmitted	I:C0036917
infection	I:C0036917
(	O
sexually	O
transmitted	I:C0036917
infection	I:C0036917
)	O
among	O
young	O
women	O
,	O
can	O
result	O
in	O
serious	O
sequelae	O
.	O

Chlamydia	O
trachomatis	I:C0008151
(	O
Chlamydia	O
trachomatis	I:C0008151
)	O
,	O
the	O
most	O
common	O
bacterial	O
sexually	I:C0036917
transmitted	I:C0036917
infection	I:C0036917
(	O
sexually	B:C0036917
transmitted	I:C0036917
infection	I:C0036917
)	O
among	O
young	O
women	O
,	O
can	O
result	O
in	O
serious	O
sequelae	O
.	O

Chlamydia	O
trachomatis	I:C0008151
(	O
Chlamydia	O
trachomatis	I:C0008151
)	O
,	O
the	O
most	O
common	O
bacterial	O
sexually	I:C0036917
transmitted	I:C0036917
infection	I:C0036917
(	O
sexually	O
transmitted	I:C0036917
infection	I:C0036917
)	O
among	O
young	O
women	B:C0043210
,	O
can	O
result	O
in	O
serious	O
sequelae	O
.	O

Chlamydia	O
trachomatis	I:C0008151
(	O
Chlamydia	O
trachomatis	I:C0008151
)	O
,	O
the	O
most	O
common	O
bacterial	O
sexually	I:C0036917
transmitted	I:C0036917
infection	I:C0036917
(	O
sexually	O
transmitted	I:C0036917
infection	I:C0036917
)	O
among	O
young	O
women	O
,	O
can	O
result	O
in	O
serious	O
sequelae	B:C0243088
.	O

Although	O
the	O
course	O
of	O
infection	B:C3714514
is	O
often	O
asymptomatic	O
,	O
Chlamydia	O
trachomatis	I:C0008151
may	O
cause	O
pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
(	O
pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
)	O
,	O
leading	O
to	O
severe	O
complications	O
,	O
such	O
as	O
prolonged	O
time	O
to	O
pregnancy	O
,	O
ectopic	O
pregnancy	I:C0032987
,	O
and	O
tubal	O
factor	O
subfertility	O
.	O

Although	O
the	O
course	O
of	O
infection	O
is	O
often	O
asymptomatic	B:C0231221
,	O
Chlamydia	O
trachomatis	I:C0008151
may	O
cause	O
pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
(	O
pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
)	O
,	O
leading	O
to	O
severe	O
complications	O
,	O
such	O
as	O
prolonged	O
time	O
to	O
pregnancy	O
,	O
ectopic	O
pregnancy	I:C0032987
,	O
and	O
tubal	O
factor	O
subfertility	O
.	O

Although	O
the	O
course	O
of	O
infection	O
is	O
often	O
asymptomatic	O
,	O
Chlamydia	B:C0008151
trachomatis	I:C0008151
may	O
cause	O
pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
(	O
pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
)	O
,	O
leading	O
to	O
severe	O
complications	O
,	O
such	O
as	O
prolonged	O
time	O
to	O
pregnancy	O
,	O
ectopic	O
pregnancy	I:C0032987
,	O
and	O
tubal	O
factor	O
subfertility	O
.	O

Although	O
the	O
course	O
of	O
infection	O
is	O
often	O
asymptomatic	O
,	O
Chlamydia	O
trachomatis	I:C0008151
may	O
cause	O
pelvic	B:C0242172
inflammatory	I:C0242172
disease	I:C0242172
(	O
pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
)	O
,	O
leading	O
to	O
severe	O
complications	O
,	O
such	O
as	O
prolonged	O
time	O
to	O
pregnancy	O
,	O
ectopic	O
pregnancy	I:C0032987
,	O
and	O
tubal	O
factor	O
subfertility	O
.	O

Although	O
the	O
course	O
of	O
infection	O
is	O
often	O
asymptomatic	O
,	O
Chlamydia	O
trachomatis	I:C0008151
may	O
cause	O
pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
(	O
pelvic	B:C0242172
inflammatory	I:C0242172
disease	I:C0242172
)	O
,	O
leading	O
to	O
severe	O
complications	O
,	O
such	O
as	O
prolonged	O
time	O
to	O
pregnancy	O
,	O
ectopic	O
pregnancy	I:C0032987
,	O
and	O
tubal	O
factor	O
subfertility	O
.	O

Although	O
the	O
course	O
of	O
infection	O
is	O
often	O
asymptomatic	O
,	O
Chlamydia	O
trachomatis	I:C0008151
may	O
cause	O
pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
(	O
pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
)	O
,	O
leading	O
to	O
severe	O
complications	B:C0009566
,	O
such	O
as	O
prolonged	O
time	O
to	O
pregnancy	O
,	O
ectopic	O
pregnancy	I:C0032987
,	O
and	O
tubal	O
factor	O
subfertility	O
.	O

Although	O
the	O
course	O
of	O
infection	O
is	O
often	O
asymptomatic	O
,	O
Chlamydia	O
trachomatis	I:C0008151
may	O
cause	O
pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
(	O
pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
)	O
,	O
leading	O
to	O
severe	O
complications	O
,	O
such	O
as	O
prolonged	O
time	O
to	O
pregnancy	B:C0032961
,	O
ectopic	O
pregnancy	I:C0032987
,	O
and	O
tubal	O
factor	O
subfertility	O
.	O

Although	O
the	O
course	O
of	O
infection	O
is	O
often	O
asymptomatic	O
,	O
Chlamydia	O
trachomatis	I:C0008151
may	O
cause	O
pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
(	O
pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
)	O
,	O
leading	O
to	O
severe	O
complications	O
,	O
such	O
as	O
prolonged	O
time	O
to	O
pregnancy	O
,	O
ectopic	B:C0032987
pregnancy	I:C0032987
,	O
and	O
tubal	O
factor	O
subfertility	O
.	O

Although	O
the	O
course	O
of	O
infection	O
is	O
often	O
asymptomatic	O
,	O
Chlamydia	O
trachomatis	I:C0008151
may	O
cause	O
pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
(	O
pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
)	O
,	O
leading	O
to	O
severe	O
complications	O
,	O
such	O
as	O
prolonged	O
time	O
to	O
pregnancy	O
,	O
ectopic	O
pregnancy	I:C0032987
,	O
and	O
tubal	O
factor	O
subfertility	B:C0729353
.	O

The	O
risk	O
of	O
and	O
risk	B:C0035648
factors	I:C0035648
for	O
complications	O
following	O
CT	O
-	I:C0518948
infection	I:C0518948
have	O
not	O
been	O
assessed	O
in	O
a	O
long	O
-	O
term	O
prospective	O
cohort	I:C1709709
study	I:C1709709
,	O
the	O
preferred	O
design	O
to	O
define	O
infections	O
and	O
complications	O
adequately	O
.	O

The	O
risk	O
of	O
and	O
risk	O
factors	I:C0035648
for	O
complications	B:C0009566
following	O
CT	O
-	I:C0518948
infection	I:C0518948
have	O
not	O
been	O
assessed	O
in	O
a	O
long	O
-	O
term	O
prospective	O
cohort	I:C1709709
study	I:C1709709
,	O
the	O
preferred	O
design	O
to	O
define	O
infections	O
and	O
complications	O
adequately	O
.	O

The	O
risk	O
of	O
and	O
risk	O
factors	I:C0035648
for	O
complications	O
following	O
CT	B:C0518948
-	I:C0518948
infection	I:C0518948
have	O
not	O
been	O
assessed	O
in	O
a	O
long	O
-	O
term	O
prospective	O
cohort	I:C1709709
study	I:C1709709
,	O
the	O
preferred	O
design	O
to	O
define	O
infections	O
and	O
complications	O
adequately	O
.	O

The	O
risk	O
of	O
and	O
risk	O
factors	I:C0035648
for	O
complications	O
following	O
CT	O
-	I:C0518948
infection	I:C0518948
have	O
not	O
been	O
assessed	O
in	O
a	O
long	O
-	O
term	O
prospective	B:C1709709
cohort	I:C1709709
study	I:C1709709
,	O
the	O
preferred	O
design	O
to	O
define	O
infections	O
and	O
complications	O
adequately	O
.	O

The	O
risk	O
of	O
and	O
risk	O
factors	I:C0035648
for	O
complications	O
following	O
CT	O
-	I:C0518948
infection	I:C0518948
have	O
not	O
been	O
assessed	O
in	O
a	O
long	O
-	O
term	O
prospective	O
cohort	I:C1709709
study	I:C1709709
,	O
the	O
preferred	O
design	O
to	O
define	O
infections	B:C3714514
and	O
complications	O
adequately	O
.	O

The	O
risk	O
of	O
and	O
risk	O
factors	I:C0035648
for	O
complications	O
following	O
CT	O
-	I:C0518948
infection	I:C0518948
have	O
not	O
been	O
assessed	O
in	O
a	O
long	O
-	O
term	O
prospective	O
cohort	I:C1709709
study	I:C1709709
,	O
the	O
preferred	O
design	O
to	O
define	O
infections	O
and	O
complications	B:C0009566
adequately	O
.	O

In	O
the	O
Netherlands	B:C0242481
Chlamydia	I:C0242481
Cohort	I:C0242481
Study	I:C0242481
(	O
Netherlands	O
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
)	O
,	O
a	O
cohort	O
of	O
women	O
of	O
reproductive	O
age	O
with	O
and	O
without	O
a	O
history	O
of	O
CT	O
-	I:C0518948
infection	I:C0518948
is	O
followed	O
over	O
a	O
minimum	O
of	O
ten	O
years	O
to	O
investigate	O
(	O
Chlamydia	O
trachomatis	I:C0008151
-	O
related	O
)	O
reproductive	O
tract	I:C0700038
complications	O
.	O

In	O
the	O
Netherlands	O
Chlamydia	I:C0242481
Cohort	I:C0242481
Study	I:C0242481
(	O
Netherlands	B:C0242481
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
)	O
,	O
a	O
cohort	O
of	O
women	O
of	O
reproductive	O
age	O
with	O
and	O
without	O
a	O
history	O
of	O
CT	O
-	I:C0518948
infection	I:C0518948
is	O
followed	O
over	O
a	O
minimum	O
of	O
ten	O
years	O
to	O
investigate	O
(	O
Chlamydia	O
trachomatis	I:C0008151
-	O
related	O
)	O
reproductive	O
tract	I:C0700038
complications	O
.	O

In	O
the	O
Netherlands	O
Chlamydia	I:C0242481
Cohort	I:C0242481
Study	I:C0242481
(	O
Netherlands	O
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
)	O
,	O
a	O
cohort	B:C0599755
of	O
women	O
of	O
reproductive	O
age	O
with	O
and	O
without	O
a	O
history	O
of	O
CT	O
-	I:C0518948
infection	I:C0518948
is	O
followed	O
over	O
a	O
minimum	O
of	O
ten	O
years	O
to	O
investigate	O
(	O
Chlamydia	O
trachomatis	I:C0008151
-	O
related	O
)	O
reproductive	O
tract	I:C0700038
complications	O
.	O

In	O
the	O
Netherlands	O
Chlamydia	I:C0242481
Cohort	I:C0242481
Study	I:C0242481
(	O
Netherlands	O
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
)	O
,	O
a	O
cohort	O
of	O
women	B:C0043210
of	O
reproductive	O
age	O
with	O
and	O
without	O
a	O
history	O
of	O
CT	O
-	I:C0518948
infection	I:C0518948
is	O
followed	O
over	O
a	O
minimum	O
of	O
ten	O
years	O
to	O
investigate	O
(	O
Chlamydia	O
trachomatis	I:C0008151
-	O
related	O
)	O
reproductive	O
tract	I:C0700038
complications	O
.	O

In	O
the	O
Netherlands	O
Chlamydia	I:C0242481
Cohort	I:C0242481
Study	I:C0242481
(	O
Netherlands	O
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
)	O
,	O
a	O
cohort	O
of	O
women	O
of	O
reproductive	O
age	O
with	O
and	O
without	O
a	O
history	B:C0262926
of	O
CT	O
-	I:C0518948
infection	I:C0518948
is	O
followed	O
over	O
a	O
minimum	O
of	O
ten	O
years	O
to	O
investigate	O
(	O
Chlamydia	O
trachomatis	I:C0008151
-	O
related	O
)	O
reproductive	O
tract	I:C0700038
complications	O
.	O

In	O
the	O
Netherlands	O
Chlamydia	I:C0242481
Cohort	I:C0242481
Study	I:C0242481
(	O
Netherlands	O
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
)	O
,	O
a	O
cohort	O
of	O
women	O
of	O
reproductive	O
age	O
with	O
and	O
without	O
a	O
history	O
of	O
CT	B:C0518948
-	I:C0518948
infection	I:C0518948
is	O
followed	O
over	O
a	O
minimum	O
of	O
ten	O
years	O
to	O
investigate	O
(	O
Chlamydia	O
trachomatis	I:C0008151
-	O
related	O
)	O
reproductive	O
tract	I:C0700038
complications	O
.	O

In	O
the	O
Netherlands	O
Chlamydia	I:C0242481
Cohort	I:C0242481
Study	I:C0242481
(	O
Netherlands	O
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
)	O
,	O
a	O
cohort	O
of	O
women	O
of	O
reproductive	O
age	O
with	O
and	O
without	O
a	O
history	O
of	O
CT	O
-	I:C0518948
infection	I:C0518948
is	O
followed	O
over	O
a	O
minimum	O
of	O
ten	O
years	O
to	O
investigate	O
(	O
Chlamydia	B:C0008151
trachomatis	I:C0008151
-	O
related	O
)	O
reproductive	O
tract	I:C0700038
complications	O
.	O

In	O
the	O
Netherlands	O
Chlamydia	I:C0242481
Cohort	I:C0242481
Study	I:C0242481
(	O
Netherlands	O
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
)	O
,	O
a	O
cohort	O
of	O
women	O
of	O
reproductive	O
age	O
with	O
and	O
without	O
a	O
history	O
of	O
CT	O
-	I:C0518948
infection	I:C0518948
is	O
followed	O
over	O
a	O
minimum	O
of	O
ten	O
years	O
to	O
investigate	O
(	O
Chlamydia	O
trachomatis	I:C0008151
-	O
related	O
)	O
reproductive	B:C0700038
tract	I:C0700038
complications	O
.	O

In	O
the	O
Netherlands	O
Chlamydia	I:C0242481
Cohort	I:C0242481
Study	I:C0242481
(	O
Netherlands	O
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
)	O
,	O
a	O
cohort	O
of	O
women	O
of	O
reproductive	O
age	O
with	O
and	O
without	O
a	O
history	O
of	O
CT	O
-	I:C0518948
infection	I:C0518948
is	O
followed	O
over	O
a	O
minimum	O
of	O
ten	O
years	O
to	O
investigate	O
(	O
Chlamydia	O
trachomatis	I:C0008151
-	O
related	O
)	O
reproductive	O
tract	I:C0700038
complications	B:C0009566
.	O

This	O
study	O
is	O
a	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
of	O
the	O
Chlamydia	O
Screening	I:C2711835
Implementation	I:C2711835
(	I:C2711835
CSI	I:C2711835
)	I:C2711835
study	I:C2711835
,	O
executed	O
between	O
2008	O
and	O
2011	O
in	O
the	O
Netherlands	O
.	O

This	O
study	O
is	O
a	O
follow	O
-	I:C1522577
up	I:C1522577
of	O
the	O
Chlamydia	B:C2711835
Screening	I:C2711835
Implementation	I:C2711835
(	I:C2711835
CSI	I:C2711835
)	I:C2711835
study	I:C2711835
,	O
executed	O
between	O
2008	O
and	O
2011	O
in	O
the	O
Netherlands	O
.	O

This	O
study	O
is	O
a	O
follow	O
-	I:C1522577
up	I:C1522577
of	O
the	O
Chlamydia	O
Screening	I:C2711835
Implementation	I:C2711835
(	I:C2711835
CSI	I:C2711835
)	I:C2711835
study	I:C2711835
,	O
executed	O
between	O
2008	O
and	O
2011	O
in	O
the	O
Netherlands	B:C0027778
.	O

For	O
Netherlands	B:C0242481
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
,	O
female	O
Chlamydia	O
Screening	I:C2711835
Implementation	I:C2711835
participants	O
who	O
consented	O
to	O
be	O
approached	O
for	O
follow	O
-	I:C0016441
up	I:C0016441
studies	I:C0016441
(	O
n	O
=	O
14,685	O
)	O
are	O
invited	O
,	O
and	O
prospectively	O
followed	O
until	O
2022	O
.	O

For	O
Netherlands	O
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
,	O
female	O
Chlamydia	B:C2711835
Screening	I:C2711835
Implementation	I:C2711835
participants	O
who	O
consented	O
to	O
be	O
approached	O
for	O
follow	O
-	I:C0016441
up	I:C0016441
studies	I:C0016441
(	O
n	O
=	O
14,685	O
)	O
are	O
invited	O
,	O
and	O
prospectively	O
followed	O
until	O
2022	O
.	O

For	O
Netherlands	O
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
,	O
female	O
Chlamydia	O
Screening	I:C2711835
Implementation	I:C2711835
participants	B:C0679646
who	O
consented	O
to	O
be	O
approached	O
for	O
follow	O
-	I:C0016441
up	I:C0016441
studies	I:C0016441
(	O
n	O
=	O
14,685	O
)	O
are	O
invited	O
,	O
and	O
prospectively	O
followed	O
until	O
2022	O
.	O

For	O
Netherlands	O
Chlamydia	I:C0242481
cohort	I:C0242481
study	I:C0242481
,	O
female	O
Chlamydia	O
Screening	I:C2711835
Implementation	I:C2711835
participants	O
who	O
consented	O
to	O
be	O
approached	O
for	O
follow	B:C0016441
-	I:C0016441
up	I:C0016441
studies	I:C0016441
(	O
n	O
=	O
14,685	O
)	O
are	O
invited	O
,	O
and	O
prospectively	O
followed	O
until	O
2022	O
.	O

Four	O
data	B:C0010995
collection	I:C0010995
moments	O
are	O
foreseen	O
every	O
two	O
consecutive	O
years	O
.	O

Questionnaire	B:C0034394
data	O
and	O
blood	O
samples	I:C0178913
for	O
Chlamydia	O
trachomatis	I:C0008151
-	O
Immunoglobulin	O
G	I:C0202087
(	I:C0202087
IgG	I:C0202087
)	I:C0202087
measurement	I:C0202087
are	O
obtained	O
as	O
well	O
as	O
host	O
DNA	I:C0012854
to	O
determine	O
specific	O
genetic	O
biomarkers	O
related	O
to	O
susceptibility	O
and	O
severity	O
of	I:C0517627
infection	I:C0517627
.	O

Questionnaire	O
data	O
and	O
blood	B:C0178913
samples	I:C0178913
for	O
Chlamydia	O
trachomatis	I:C0008151
-	O
Immunoglobulin	O
G	I:C0202087
(	I:C0202087
IgG	I:C0202087
)	I:C0202087
measurement	I:C0202087
are	O
obtained	O
as	O
well	O
as	O
host	O
DNA	I:C0012854
to	O
determine	O
specific	O
genetic	O
biomarkers	O
related	O
to	O
susceptibility	O
and	O
severity	O
of	I:C0517627
infection	I:C0517627
.	O

Questionnaire	O
data	O
and	O
blood	O
samples	I:C0178913
for	O
Chlamydia	B:C0008151
trachomatis	I:C0008151
-	O
Immunoglobulin	O
G	I:C0202087
(	I:C0202087
IgG	I:C0202087
)	I:C0202087
measurement	I:C0202087
are	O
obtained	O
as	O
well	O
as	O
host	O
DNA	I:C0012854
to	O
determine	O
specific	O
genetic	O
biomarkers	O
related	O
to	O
susceptibility	O
and	O
severity	O
of	I:C0517627
infection	I:C0517627
.	O

Questionnaire	O
data	O
and	O
blood	O
samples	I:C0178913
for	O
Chlamydia	O
trachomatis	I:C0008151
-	O
Immunoglobulin	B:C0202087
G	I:C0202087
(	I:C0202087
IgG	I:C0202087
)	I:C0202087
measurement	I:C0202087
are	O
obtained	O
as	O
well	O
as	O
host	O
DNA	I:C0012854
to	O
determine	O
specific	O
genetic	O
biomarkers	O
related	O
to	O
susceptibility	O
and	O
severity	O
of	I:C0517627
infection	I:C0517627
.	O

Questionnaire	O
data	O
and	O
blood	O
samples	I:C0178913
for	O
Chlamydia	O
trachomatis	I:C0008151
-	O
Immunoglobulin	O
G	I:C0202087
(	I:C0202087
IgG	I:C0202087
)	I:C0202087
measurement	I:C0202087
are	O
obtained	O
as	O
well	O
as	O
host	B:C0012854
DNA	I:C0012854
to	O
determine	O
specific	O
genetic	O
biomarkers	O
related	O
to	O
susceptibility	O
and	O
severity	O
of	I:C0517627
infection	I:C0517627
.	O

Questionnaire	O
data	O
and	O
blood	O
samples	I:C0178913
for	O
Chlamydia	O
trachomatis	I:C0008151
-	O
Immunoglobulin	O
G	I:C0202087
(	I:C0202087
IgG	I:C0202087
)	I:C0202087
measurement	I:C0202087
are	O
obtained	O
as	O
well	O
as	O
host	O
DNA	I:C0012854
to	O
determine	O
specific	O
genetic	O
biomarkers	B:C0005516
related	O
to	O
susceptibility	O
and	O
severity	O
of	I:C0517627
infection	I:C0517627
.	O

Questionnaire	O
data	O
and	O
blood	O
samples	I:C0178913
for	O
Chlamydia	O
trachomatis	I:C0008151
-	O
Immunoglobulin	O
G	I:C0202087
(	I:C0202087
IgG	I:C0202087
)	I:C0202087
measurement	I:C0202087
are	O
obtained	O
as	O
well	O
as	O
host	O
DNA	I:C0012854
to	O
determine	O
specific	O
genetic	O
biomarkers	O
related	O
to	O
susceptibility	O
and	O
severity	B:C0517627
of	I:C0517627
infection	I:C0517627
.	O

Chlamydia	B:C0008151
trachomatis	I:C0008151
-	O
history	O
will	O
be	O
based	O
on	O
CSI	O
test	I:C2711835
outcomes	O
,	O
self	O
-	I:C0681906
reported	I:C0681906
infections	O
and	O
Chlamydia	O
trachomatis	I:C0008151
-	O
Immunoglobulin	O
G	I:C0020852
presence	O
.	O

Chlamydia	O
trachomatis	I:C0008151
-	O
history	B:C0262926
will	O
be	O
based	O
on	O
CSI	O
test	I:C2711835
outcomes	O
,	O
self	O
-	I:C0681906
reported	I:C0681906
infections	O
and	O
Chlamydia	O
trachomatis	I:C0008151
-	O
Immunoglobulin	O
G	I:C0020852
presence	O
.	O

Chlamydia	O
trachomatis	I:C0008151
-	O
history	O
will	O
be	O
based	O
on	O
CSI	B:C2711835
test	I:C2711835
outcomes	O
,	O
self	O
-	I:C0681906
reported	I:C0681906
infections	O
and	O
Chlamydia	O
trachomatis	I:C0008151
-	O
Immunoglobulin	O
G	I:C0020852
presence	O
.	O

Chlamydia	O
trachomatis	I:C0008151
-	O
history	O
will	O
be	O
based	O
on	O
CSI	O
test	I:C2711835
outcomes	O
,	O
self	B:C0681906
-	I:C0681906
reported	I:C0681906
infections	O
and	O
Chlamydia	O
trachomatis	I:C0008151
-	O
Immunoglobulin	O
G	I:C0020852
presence	O
.	O

Chlamydia	O
trachomatis	I:C0008151
-	O
history	O
will	O
be	O
based	O
on	O
CSI	O
test	I:C2711835
outcomes	O
,	O
self	O
-	I:C0681906
reported	I:C0681906
infections	B:C3714514
and	O
Chlamydia	O
trachomatis	I:C0008151
-	O
Immunoglobulin	O
G	I:C0020852
presence	O
.	O

Chlamydia	O
trachomatis	I:C0008151
-	O
history	O
will	O
be	O
based	O
on	O
CSI	O
test	I:C2711835
outcomes	O
,	O
self	O
-	I:C0681906
reported	I:C0681906
infections	O
and	O
Chlamydia	B:C0008151
trachomatis	I:C0008151
-	O
Immunoglobulin	O
G	I:C0020852
presence	O
.	O

Chlamydia	O
trachomatis	I:C0008151
-	O
history	O
will	O
be	O
based	O
on	O
CSI	O
test	I:C2711835
outcomes	O
,	O
self	O
-	I:C0681906
reported	I:C0681906
infections	O
and	O
Chlamydia	O
trachomatis	I:C0008151
-	O
Immunoglobulin	B:C0020852
G	I:C0020852
presence	O
.	O

Information	O
on	O
(	O
time	O
to	O
)	O
pregnancies	B:C0032961
and	O
the	O
potential	O
long	O
-	O
term	O
complications	O
(	O
i.e.	O
pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
,	O
ectopic	O
pregnancy	I:C0032987
and	O
(	O
tubal	O
factor	O
)	O
subfertility	O
)	O
,	O
will	O
be	O
acquired	O
by	O
questionnaires	O
.	O

Information	O
on	O
(	O
time	O
to	O
)	O
pregnancies	O
and	O
the	O
potential	O
long	O
-	O
term	O
complications	B:C0009566
(	O
i.e.	O
pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
,	O
ectopic	O
pregnancy	I:C0032987
and	O
(	O
tubal	O
factor	O
)	O
subfertility	O
)	O
,	O
will	O
be	O
acquired	O
by	O
questionnaires	O
.	O

Information	O
on	O
(	O
time	O
to	O
)	O
pregnancies	O
and	O
the	O
potential	O
long	O
-	O
term	O
complications	O
(	O
i.e.	O
pelvic	B:C0242172
inflammatory	I:C0242172
disease	I:C0242172
,	O
ectopic	O
pregnancy	I:C0032987
and	O
(	O
tubal	O
factor	O
)	O
subfertility	O
)	O
,	O
will	O
be	O
acquired	O
by	O
questionnaires	O
.	O

Information	O
on	O
(	O
time	O
to	O
)	O
pregnancies	O
and	O
the	O
potential	O
long	O
-	O
term	O
complications	O
(	O
i.e.	O
pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
,	O
ectopic	B:C0032987
pregnancy	I:C0032987
and	O
(	O
tubal	O
factor	O
)	O
subfertility	O
)	O
,	O
will	O
be	O
acquired	O
by	O
questionnaires	O
.	O

Information	O
on	O
(	O
time	O
to	O
)	O
pregnancies	O
and	O
the	O
potential	O
long	O
-	O
term	O
complications	O
(	O
i.e.	O
pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
,	O
ectopic	O
pregnancy	I:C0032987
and	O
(	O
tubal	O
factor	O
)	O
subfertility	B:C0729353
)	O
,	O
will	O
be	O
acquired	O
by	O
questionnaires	O
.	O

Information	O
on	O
(	O
time	O
to	O
)	O
pregnancies	O
and	O
the	O
potential	O
long	O
-	O
term	O
complications	O
(	O
i.e.	O
pelvic	O
inflammatory	I:C0242172
disease	I:C0242172
,	O
ectopic	O
pregnancy	I:C0032987
and	O
(	O
tubal	O
factor	O
)	O
subfertility	O
)	O
,	O
will	O
be	O
acquired	O
by	O
questionnaires	B:C0034394
.	O

Reported	B:C0700287
subfertility	O
will	O
be	O
verified	O
in	O
medical	O
registers	I:C0034975
.	O

Reported	O
subfertility	B:C0729353
will	O
be	O
verified	O
in	O
medical	O
registers	I:C0034975
.	O

Reported	O
subfertility	O
will	O
be	O
verified	O
in	O
medical	B:C0034975
registers	I:C0034975
.	O

Occurrence	O
of	O
these	O
late	O
complications	B:C0009566
and	O
prolonged	O
time	O
to	O
pregnancy	O
,	O
as	O
a	O
proxy	O
for	O
reduced	O
fertility	I:C1867795
due	O
to	O
a	O
previous	O
CT	O
-	I:C0518948
infection	I:C0518948
,	O
or	O
other	O
risk	O
factors	I:C0035648
,	O
will	O
be	O
investigated	O
using	O
longitudinal	O
statistical	I:C0920317
procedures	I:C0920317
.	O

Occurrence	O
of	O
these	O
late	O
complications	O
and	O
prolonged	O
time	O
to	O
pregnancy	B:C0032961
,	O
as	O
a	O
proxy	O
for	O
reduced	O
fertility	I:C1867795
due	O
to	O
a	O
previous	O
CT	O
-	I:C0518948
infection	I:C0518948
,	O
or	O
other	O
risk	O
factors	I:C0035648
,	O
will	O
be	O
investigated	O
using	O
longitudinal	O
statistical	I:C0920317
procedures	I:C0920317
.	O

Occurrence	O
of	O
these	O
late	O
complications	O
and	O
prolonged	O
time	O
to	O
pregnancy	O
,	O
as	O
a	O
proxy	O
for	O
reduced	B:C1867795
fertility	I:C1867795
due	O
to	O
a	O
previous	O
CT	O
-	I:C0518948
infection	I:C0518948
,	O
or	O
other	O
risk	O
factors	I:C0035648
,	O
will	O
be	O
investigated	O
using	O
longitudinal	O
statistical	I:C0920317
procedures	I:C0920317
.	O

Occurrence	O
of	O
these	O
late	O
complications	O
and	O
prolonged	O
time	O
to	O
pregnancy	O
,	O
as	O
a	O
proxy	O
for	O
reduced	O
fertility	I:C1867795
due	O
to	O
a	O
previous	O
CT	B:C0518948
-	I:C0518948
infection	I:C0518948
,	O
or	O
other	O
risk	O
factors	I:C0035648
,	O
will	O
be	O
investigated	O
using	O
longitudinal	O
statistical	I:C0920317
procedures	I:C0920317
.	O

Occurrence	O
of	O
these	O
late	O
complications	O
and	O
prolonged	O
time	O
to	O
pregnancy	O
,	O
as	O
a	O
proxy	O
for	O
reduced	O
fertility	I:C1867795
due	O
to	O
a	O
previous	O
CT	O
-	I:C0518948
infection	I:C0518948
,	O
or	O
other	O
risk	B:C0035648
factors	I:C0035648
,	O
will	O
be	O
investigated	O
using	O
longitudinal	O
statistical	I:C0920317
procedures	I:C0920317
.	O

Occurrence	O
of	O
these	O
late	O
complications	O
and	O
prolonged	O
time	O
to	O
pregnancy	O
,	O
as	O
a	O
proxy	O
for	O
reduced	O
fertility	I:C1867795
due	O
to	O
a	O
previous	O
CT	O
-	I:C0518948
infection	I:C0518948
,	O
or	O
other	O
risk	O
factors	I:C0035648
,	O
will	O
be	O
investigated	O
using	O
longitudinal	B:C0920317
statistical	I:C0920317
procedures	I:C0920317
.	O

In	O
the	O
proposed	O
study	O
,	O
the	O
occurrence	O
of	O
late	O
complications	B:C0009566
following	O
CT	O
-	I:C0518948
infection	I:C0518948
and	O
its	O
risk	O
factors	I:C0035648
will	O
be	O
assessed	O
.	O

In	O
the	O
proposed	O
study	O
,	O
the	O
occurrence	O
of	O
late	O
complications	O
following	O
CT	B:C0518948
-	I:C0518948
infection	I:C0518948
and	O
its	O
risk	O
factors	I:C0035648
will	O
be	O
assessed	O
.	O

In	O
the	O
proposed	O
study	O
,	O
the	O
occurrence	O
of	O
late	O
complications	O
following	O
CT	O
-	I:C0518948
infection	I:C0518948
and	O
its	O
risk	B:C0035648
factors	I:C0035648
will	O
be	O
assessed	O
.	O

Ultimately	O
,	O
provided	O
reliable	O
risk	B:C0035648
factors	I:C0035648
and	O
/	O
or	O
markers	O
can	O
be	O
identified	O
for	O
such	O
late	O
complications	O
.	O

Ultimately	O
,	O
provided	O
reliable	O
risk	O
factors	I:C0035648
and	O
/	O
or	O
markers	B:C0005516
can	O
be	O
identified	O
for	O
such	O
late	O
complications	O
.	O

Ultimately	O
,	O
provided	O
reliable	O
risk	O
factors	I:C0035648
and	O
/	O
or	O
markers	O
can	O
be	O
identified	O
for	O
such	O
late	O
complications	B:C0009566
.	O

This	O
will	O
contribute	O
to	O
the	O
development	O
of	O
a	O
prognostic	B:C0220901
tool	O
to	O
estimate	O
the	O
risk	O
of	O
Chlamydia	O
trachomatis	I:C0008151
-	O
related	O
complications	O
at	O
an	O
early	O
time	O
point	O
,	O
enabling	O
targeted	O
prevention	O
and	O
care	O
towards	O
women	O
at	O
risk	O
for	O
late	O
complications	O
.	O

This	O
will	O
contribute	O
to	O
the	O
development	O
of	O
a	O
prognostic	O
tool	O
to	O
estimate	O
the	O
risk	O
of	O
Chlamydia	B:C0008151
trachomatis	I:C0008151
-	O
related	O
complications	O
at	O
an	O
early	O
time	O
point	O
,	O
enabling	O
targeted	O
prevention	O
and	O
care	O
towards	O
women	O
at	O
risk	O
for	O
late	O
complications	O
.	O

This	O
will	O
contribute	O
to	O
the	O
development	O
of	O
a	O
prognostic	O
tool	O
to	O
estimate	O
the	O
risk	O
of	O
Chlamydia	O
trachomatis	I:C0008151
-	O
related	O
complications	B:C0009566
at	O
an	O
early	O
time	O
point	O
,	O
enabling	O
targeted	O
prevention	O
and	O
care	O
towards	O
women	O
at	O
risk	O
for	O
late	O
complications	O
.	O

This	O
will	O
contribute	O
to	O
the	O
development	O
of	O
a	O
prognostic	O
tool	O
to	O
estimate	O
the	O
risk	O
of	O
Chlamydia	O
trachomatis	I:C0008151
-	O
related	O
complications	O
at	O
an	O
early	O
time	O
point	O
,	O
enabling	O
targeted	O
prevention	O
and	O
care	O
towards	O
women	B:C0043210
at	O
risk	O
for	O
late	O
complications	O
.	O

This	O
will	O
contribute	O
to	O
the	O
development	O
of	O
a	O
prognostic	O
tool	O
to	O
estimate	O
the	O
risk	O
of	O
Chlamydia	O
trachomatis	I:C0008151
-	O
related	O
complications	O
at	O
an	O
early	O
time	O
point	O
,	O
enabling	O
targeted	O
prevention	O
and	O
care	O
towards	O
women	O
at	O
risk	O
for	O
late	O
complications	B:C0009566
.	O

